We demonstrate that surprisingly, CAR T cell-mediated cytotoxicity is not significantly impacted by overexpression of PI9 within tumor cells; rather, redundancy in cytotoxic pathways ensures that compensatory cytotoxic mechanisms including GZMA for liquid tumor targets and FasL for solid tumor targets preserve CAR T cell cytotoxicity. This evidence concerns the gene GZMA and neoplasm.